STAT Plus: Pfizer to invest up to $500M in public companies with drugs in the clinic
SPENCER PLATT/GETTY IMAGES
The program would give companies access to the company’s scientists, clinicians, and manufacturing experts, if they want it.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario